You are here: Home » News-CM » Companies » Results
Business Standard

Beryl Drugs standalone net profit rises 70.00% in the June 2019 quarter

Capital Market 

Sales rise 2.17% to Rs 4.23 crore

Net profit of Beryl Drugs rose 70.00% to Rs 0.34 crore in the quarter ended June 2019 as against Rs 0.20 crore during the previous quarter ended June 2018. Sales rose 2.17% to Rs 4.23 crore in the quarter ended June 2019 as against Rs 4.14 crore during the previous quarter ended June 2018. ParticularsQuarter EndedJun. 2019Jun. 2018% Var.Sales4.234.14 2 OPM %13.719.42 -PBDT0.480.35 37 PBT0.380.25 52 NP0.340.20 70

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Sat, August 10 2019. 11:24 IST
RECOMMENDED FOR YOU
RECOMMENDED FOR YOU